Goldman Sachs Files Free Writing Prospectus

TL;DR

GS filed an FWP on 4/7/26. New offering incoming.

AI Summary

On April 7, 2026, Goldman Sachs Group Inc. filed a Free Writing Prospectus (FWP) under Securities Act Rules 163/433. This filing, with SEC Accession No. 0001193125-26-145322, relates to a financial offering. The filing was accepted on the same date.

Why It Matters

This filing indicates Goldman Sachs is actively engaging in capital markets activities, potentially related to new debt or equity offerings, which could impact its financial structure and investor base.

Risk Assessment

Risk Level: low — This is a standard regulatory filing for a financial institution and does not inherently indicate increased risk.

Key Numbers

• 119945 — FWP Document Size (Size of the Free Writing Prospectus document in bytes.)
• 126163 — Submission Text File Size (Size of the complete submission text file in bytes.)

Key Players & Entities

• Goldman Sachs Group Inc. (company) — Subject of the filing
• 0000886982 (company) — CIK number for Goldman Sachs Group Inc.
• 0001193125-26-145322 (dollar_amount) — SEC Accession Number for the filing
• 2026-04-07 (date) — Filing date

FAQ

Key Financial Figures

• $1,000 — 2, 2029 Payment at maturity (for each $1,000 stated principal amount of your securit
• $33.75 — to the buffer price, (i) the product of $33.75 times the number of coupon observation
• $0.00 — ion date is less than the buffer price, $0.00 150.000% 100.000%* 125.000% 100
• $895 — 0% 50.000% Estimated value range: $895 to $955 (which is less than the origina
• $955 — 000% Estimated value range: $895 to $955 (which is less than the original issue

Filing Documents

• vrtca005_fwp_gsg.htm (FWP) — 117KB
• img149999899_0.jpg (GRAPHIC) — 3KB
• 0001193125-26-145322.txt ( ) — 123KB

RISK FACTORS

RISK FACTORS An investment in the securities is subject to risks. Many of the risks are described in the accompanying preliminary pricing supplement, accompanying general terms supplement no. 17,745, accompanying prospectus supplement and accompanying prospectus. Below we have provided a list of certain risk factors discussed in such documents. In addition to the below, you should read in full “Risk Factors” in the accompanying preliminary pricing supplement, “Additional Risk Factors Specific to the Notes” in the accompanying general terms supplement no. 17,745, as well as the risks and considerations described in the accompanying prospectus supplement and accompanying prospectus. Your securities are a riskier investment than ordinary debt securities. Also, your securities are not equivalent to investing directly in the underlying stock. You should carefully consider whether the offered securities are appropriate given your particular circumstances. The following risk factors are discussed in greater detail in the accompanying preliminary pricing supplement: Risks Related to Structure, Valuation and Secondary Market Sales ▪ You May Lose Your Entire Investment in the Securities ▪ The Securities Are Subject to the Credit Risk of the Issuer and the Guarantor ▪ You May Not Receive a Contingent Quarterly Coupon on Any Coupon Payment Date ▪ Your Securities Are Subject to Automatic Redemption ▪ The Contingent Quarterly Coupon Does Not Reflect the Actual Performance of the Underlying Stock from the Pricing Date to Any Coupon Observation Date or from Coupon Observation Date to Coupon Observation Date and Investors Will Not Participate in Any Appreciation of the Underlying Stock ▪ T he Estimated Value of Your Securities At the Time the Terms of Your Securities Are Set On the Pricing Date (as Determined By Reference to Pricing Models Used By GS&Co.) Is Less Than the Original Issue Price Of